The medical diagnostics industry has found an ally in its quest to restore patent eligibility for groundbreaking discoveries, even those involving natural phenomena.

Judge Kathleen O’Malley of the U.S. Court of Appeals for the Federal Circuit called on the full court to review its case law Tuesday even while voting to affirm the latest invalidation, this time on a Roche patent for quickly diagnosing drug-resistant tuberculosis.